Skip to main content
. Author manuscript; available in PMC: 2011 Apr 1.
Published in final edited form as: Nat Genet. 2010 Sep 5;42(10):851–858. doi: 10.1038/ng.659

Table 1.

Clinical and other features of patient cohort

Patients with:
Clinical Diagnosis mtDNA mutations nuclear mutations unknown mutations
Leigh Syndrome 11 6 15
Other mitochondrial encephalopathy 3 1 13
Cardiomyopathy/encephalopathy 0 2 12
LIMD 2 6a 9
MELAS 6 0 0
Mitochondrial myopathy 2 0 5
Mitochondrial cytopathy 1 0 3
Mitochondrial hepatopathy 0 3 2
VCFS/DiGeorge Plus 0 0 1
Total 25 18 60
Consanguinity 0 7 6
Family historyb: definite, possible 7, 9 9, 0 9, 9
Fibroblast defectc (# tested) 17 (20) 10 (15) 18 (32)
a

2 patients were affected prenatal diagnoses that were terminated and diagnosis was assumed to be the same as the proband.

b

Family history consistent with a mitochondrial disorder

c

CI enzyme defect present in patient fibroblasts

Abbreviations: LIMD, Lethal Infantile Mitochondrial Disease; MELAS, Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like episodes; VCFS, Velo-Cardio-Facial Syndrome;